QT
MRNA icon

Quantamental Technologies’s Moderna MRNA Stock Holding History

Quantamental Technologies’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,963
Closed -$469K – 588
2022
Q3 		$469K Buy
+3,963
New +$601K 0.18% 200
2021
Q4 		– Sell
-912
Closed -$351K – 465
2021
Q3 		$351K Buy
+912
New +$336K 0.23% 153
2020
Q4 		– Sell
-3,190
Closed -$226K – 210
2020
Q3 		$226K Buy
+3,190
New +$222K 0.17% 211
2019
Q4 		– Sell
-3,000
Closed -$48K – 988
2019
Q3 		$48K Buy
+3,000
New +$44.3K 0.02% 977

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantamental Technologies's MRNA Position: Q4 2022 in Review

Quantamental Technologies sold out of Moderna (MRNA) in Q4 2022, closing a stake of 3,963 shares — an estimated $469K sold.

Quantamental Technologies first reported a position in MRNA in Q3 2019 and held it in 4 quarters. The position peaked at $469K in Q3 2022. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Quantamental Technologies reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 3,963 Moderna shares in Q4 2022, an estimated $469K.
  • Quantamental Technologies first reported a position in Moderna in Q3 2019 and held it in 4 quarters.
  • Quantamental Technologies's Moderna position peaked at $469K in Q3 2022.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.